BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 23142767)

  • 1. Metallostasis in Alzheimer's disease.
    Ayton S; Lei P; Bush AI
    Free Radic Biol Med; 2013 Sep; 62():76-89. PubMed ID: 23142767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metal Ions in Alzheimer's Disease: A Key Role or Not?
    Liu Y; Nguyen M; Robert A; Meunier B
    Acc Chem Res; 2019 Jul; 52(7):2026-2035. PubMed ID: 31274278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metal theory of Alzheimer's disease.
    Bush AI
    J Alzheimers Dis; 2013; 33 Suppl 1():S277-81. PubMed ID: 22635102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metals and Alzheimer's disease.
    Adlard PA; Bush AI
    J Alzheimers Dis; 2006 Nov; 10(2-3):145-63. PubMed ID: 17119284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metals and amyloid-beta in Alzheimer's disease.
    Maynard CJ; Bush AI; Masters CL; Cappai R; Li QX
    Int J Exp Pathol; 2005 Jun; 86(3):147-59. PubMed ID: 15910549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc takes the center stage: its paradoxical role in Alzheimer's disease.
    Cuajungco MP; Fagét KY
    Brain Res Brain Res Rev; 2003 Jan; 41(1):44-56. PubMed ID: 12505647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copper(I) and copper(II) inhibit Aβ peptides proteolysis by insulin-degrading enzyme differently: implications for metallostasis alteration in Alzheimer's disease.
    Grasso G; Pietropaolo A; Spoto G; Pappalardo G; Tundo GR; Ciaccio C; Coletta M; Rizzarelli E
    Chemistry; 2011 Feb; 17(9):2752-62. PubMed ID: 21274957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory Activities of Dopamine and Its Derivatives toward Metal-Free and Metal-Induced Amyloid-β Aggregation, Oxidative Stress, and Inflammation in Alzheimer's Disease.
    Nam E; Derrick JS; Lee S; Kang J; Han J; Lee SJC; Chung SW; Lim MH
    ACS Chem Neurosci; 2018 Nov; 9(11):2655-2666. PubMed ID: 29782798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metal ion hypothesis of Alzheimer's disease and the anti-neuroinflammatory effect of metal chelators.
    Chen LL; Fan YG; Zhao LX; Zhang Q; Wang ZY
    Bioorg Chem; 2023 Feb; 131():106301. PubMed ID: 36455485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copper and Zinc Dysregulation in Alzheimer's Disease.
    Sensi SL; Granzotto A; Siotto M; Squitti R
    Trends Pharmacol Sci; 2018 Dec; 39(12):1049-1063. PubMed ID: 30352697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron, Copper, and Zinc Concentration in Aβ Plaques in the APP/PS1 Mouse Model of Alzheimer's Disease Correlates with Metal Levels in the Surrounding Neuropil.
    James SA; Churches QI; de Jonge MD; Birchall IE; Streltsov V; McColl G; Adlard PA; Hare DJ
    ACS Chem Neurosci; 2017 Mar; 8(3):629-637. PubMed ID: 27958708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heme binding to Amyloid-beta peptide: mechanistic role in Alzheimer's disease.
    Atamna H
    J Alzheimers Dis; 2006 Nov; 10(2-3):255-66. PubMed ID: 17119291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of Zn(II) and Cu(II) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity.
    Tõugu V; Tiiman A; Palumaa P
    Metallomics; 2011 Mar; 3(3):250-61. PubMed ID: 21359283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cerebral amyloid angiopathy on brain iron, copper, and zinc in Alzheimer's disease.
    Schrag M; Crofton A; Zabel M; Jiffry A; Kirsch D; Dickson A; Mao XW; Vinters HV; Domaille DW; Chang CJ; Kirsch W
    J Alzheimers Dis; 2011; 24(1):137-49. PubMed ID: 21187585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides.
    Huang X; Atwood CS; Moir RD; Hartshorn MA; Tanzi RE; Bush AI
    J Biol Inorg Chem; 2004 Dec; 9(8):954-60. PubMed ID: 15578276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron, zinc and copper in the Alzheimer's disease brain: a quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion.
    Schrag M; Mueller C; Oyoyo U; Smith MA; Kirsch WM
    Prog Neurobiol; 2011 Aug; 94(3):296-306. PubMed ID: 21600264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aluminum, copper, iron and zinc differentially alter amyloid-Aβ(1-42) aggregation and toxicity.
    Bolognin S; Messori L; Drago D; Gabbiani C; Cendron L; Zatta P
    Int J Biochem Cell Biol; 2011 Jun; 43(6):877-85. PubMed ID: 21376832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Untangling amyloid-β, tau, and metals in Alzheimer's disease.
    Savelieff MG; Lee S; Liu Y; Lim MH
    ACS Chem Biol; 2013 May; 8(5):856-65. PubMed ID: 23506614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.